<DOC>
	<DOCNO>NCT02430571</DOCNO>
	<brief_summary>This prospective , single-center , open label , within-subject clinical trial evaluate identification anatomical marker gastrointestinal tract use IRIS feed tube . The trial evaluate hospitalize subject require short-term enteral feeding anticipate duration least 3 day intensive care unit ( ICU ) step-down unit . Eligible men woman least 18 year age give voluntary , write informed consent participate clinical investigation include subject . If potential subject incapacitate unable provide inform consent , designate legally authorize representative allow provide informed consent behalf subject allow participation study . Study entry define point sign informed consent . A Prospective , Single-Center , Open Label , Within-Subject Case Series Evaluate Identification Anatomical Markers Gastrointestinal Tract Using KANGAROO™ Feeding Tube IRIS Technology</brief_summary>
	<brief_title>Case Series Evaluate Identification Anatomical Markers Using KANGAROO™ Feeding Tube</brief_title>
	<detailed_description />
	<criteria>1 . Hospitalized male female patient monitor set ( i.e . ; ICU StepDown Unit ) require eligible shortterm enteral ( nasal oral ) feed per standard care expect duration least 3 day . 2 . The subject legally authorize representative able understand willing give write informed consent . 3 . Be man woman 18 year old 4 . Have uncomplicated naso oropharyngeal anatomy base upon focused physical examination 1 . Women men age 18 year 2 . Female patient know pregnant lactate 3 . Incarcerated imprisoned individual 4 . Hemodynamic instability inability maintain MAP &gt; 65 mm Hg vasopressor 5 . Patients currently enrol investigational interventional drug device clinical trial 6 . Patients previously enrol study 7 . Individuals , , opinion Principal Investigator , medical , social psychological condition would compromise participation followup clinical investigation 8 . Known basal skull fracture 9 . Unrepaired known GI perforation leak 10 . Recent adequate upper GI bleed may obscure image 11 . Esophageal varix &gt; Grade 2 12 . Subjects know anomaly preclude gastric intestinal insertion ( via either nasally orally ) 13 . Known obstruction gastrointestinal tract 14 . Known bowel ischemia contraindication enteral feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>